Mirum Pharmaceuticals, Inc. (MIRM)
$86.01+5.73%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5.2B
- Beta
- 0.49
- P/E (TTM)
- -5.44
- Short % float
- 11.48%
- Days to cover
- 7.7
- SI change
- +11.2%
- 1W
- +3.71%
- 1M
- -14.51%
- vs SPY 1W
- +2.55%
- vs SPY 1M
- -17.50%
Industry peers
FMP comparable companies · ranked by market cap
- PRAXSELLPraxis Precision Medicines, Inc.$7.9BCRISISQ 11$283.56-1.40%
- BLTESELLBelite Bio, Inc$6.4BBEARQ 53$159.18+1.29%
- LGNDBUYLigand Pharmaceuticals Incorporated$6.1BRECOVERYQ 15$306.77+2.31%
- TVTXSELLTravere Therapeutics, Inc.$5.4BCRISISQ 33$57.67+0.17%
- TLXSELLTelix Pharmaceuticals Limited$3.7BBEARQ -4$10.88+1.82%
- ACADSELLAcadia Pharmaceuticals Inc.$3.4BCRISISQ 18$20.11+1.02%
- DYNSELLDyne Therapeutics, Inc.$2.9BRECOVERYQ 3$15.44+1.65%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- ADMABUYADMA Biologics, Inc.$2.3BRECOVERYQ 9$10.11+0.29%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.4BRECOVERYQ -6$14.50+1.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on MIRM?
- LOPJLB’s latest quantitative signal on Mirum Pharmaceuticals, Inc. (MIRM) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is MIRM in?
- Mirum Pharmaceuticals, Inc. (MIRM) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Mirum Pharmaceuticals, Inc. (MIRM) do?
- Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixib…